Qiagen NV Q1 25 Earnings Conference Call At 9:00 AM ET
Research Alert: Growth Continues In Q1 2025, Qiagen Plans To Initiate Its First Dividend
Qiagen NV To Go Ex-Dividend On July 2nd, 2025 With 0.25 USD Special Dividend Per Share
Qiagen Q1 Adjusted Earnings, Revenue Rise; New $500 Million Stock Buyback Planned
Qiagen 1Q Sales $483M >QGEN
Earnings Flash (QGEN) QIAGEN Q1 Revenue $483 Million Vs. FactSet Est. $468.9 Million
Qiagen : Supervisory Bd Intends to Elect Stephen Rusckowski as Chairman After Annual Meeting >QGEN
Express News | Qiagen FY2025 Reaffirms EPS Of $2.35 CER Vs $2.49 Est
Qiagen Q1 Adj. EPS $0.55 Misses $0.56 Estimate, Sales $483.00M Miss $507.25M Estimate
QIAGEN Delivers Solid Q1 2025 Results Exceeding Outlook; Will Seek Shareholder Approval To Initiate A Dividend And New $500 Mn Repurchase >QGEN
Qiagen Plans to Initiate Dividend Payments
Press Release: QIAGEN to Propose Initiation of Annual Cash Dividend for Shareholder Approval at Annual General Meeting
What Qiagen N.V.'s (NYSE:QGEN) P/S Is Not Telling You
Earnings Preview: Qiagen NV to Report Financial Results Post-market on May 07
QIAGEN Expands Digital PCR Portfolio With New Lentivirus Solutions To Strengthen Cell And Gene Therapy Quality Control
Stifel Maintains Qiagen NV(QGEN.US) With Hold Rating, Maintains Target Price $45
UBS Initiates Qiagen NV(QGEN.US) With Hold Rating
QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025
Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 33% Undervaluation?
Baird Maintains Qiagen NV(QGEN.US) With Hold Rating, Raises Target Price to $43